IL-6 is also involved in signaling and immunoregulatory cascades by binding to its receptor (IL-6R) on gp130-positive cells – thereby activating the transcription factor signal transducer and activators of transcription 3 (STAT3) and increasing the risk of colon cancer [61, 62]. This evidence concerns the gene IL6R and colonic neoplasm.